87. Pulmonary veno-occlusive disease Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 3 / Drugs : 4 - (DrugBank : 3) / Drug target genes : 4 - Drug target pathways : 45
Drugs and their primary sponsors and trial info
Bevacizumab (Avastin) and Imatinib Mesylate (Gleevec)
Boston Children's Hospital
2008 Phase 1/Phase 2 NCT00891527 United States;
Glutamine
Hospital Authority, Hong Kong
2004 - NCT00563498 China;
Imatinib
National Hospital Organization Okayama Medical Center
2015 - JPRN-UMIN000020543 Japan;
Boston Children's Hospital
2008 Phase 1/Phase 2 NCT00891527 United States;
Glutamine
Hospital Authority, Hong Kong
2004 - NCT00563498 China;
Imatinib
National Hospital Organization Okayama Medical Center
2015 - JPRN-UMIN000020543 Japan;